Register below to secure your free ticket… Come and sample a few ‘wee drams’ with us! The team at Pinnacle 21 and newly acquired Formedix are hosting a private Scotch whiskey tasting evening – and you’re invited! The event takes place on Tuesday February 27th from 7pm at Fogo de Chao, Bethesda… just an 8 … Continued
https://www.certara.com/phuse-us-2024-whiskey-tasting/Transcript: I’ve joined companies both blueprint medicines and score therapeutics is one of the first employees with no infrastructure in place. So I have with chemists and biologists evaluated products on the markets and the conclusion both times was that Certara three sixty really is the best product out there. When you just ask a … Continued
https://www.certara.com/video/d360-scientific-informatics-discovery-platform-user-stories/By Hugo Geerts, PhD, Piet van der Graaf, PharmD, PhD Over the past 20 years, less than a handful of completed Phase III Alzheimer disease (AD) clinical trials have been successful. Despite large investments of capital and research, more than 200 investigational programs have failed or …
https://www.certara.com/article/upping-the-ante-for-predicting-the-success-of-alzheimer-disease-treatments/In a long-awaited development, Italy’s Medicines Agency, AIFA, underwent transformative changes on January 30th, 2024. This has been a recurrent topic of discussion, with talks of merging the Scientific Technical Advisory Committee (CTS) and the Price and Reimbursement Committee (CPR). However, the COVID-19 pandemic delayed these plans, leading to a continuous extension of the current … Continued
https://www.certara.com/blog/aifa-makeover-italys-leap-into-2024/Dr. Fran Brown, SVP of Drug Development Science at Certara, joins this episode of CertaraTalks to share highlights from J.P. Morgan’s BiotechShowcase 2024. Watch below for insights and key takeaways around topics like the current funding environment, the role of generative AI in the regulatory processes, and advancements in cancer medicine. Transcript: Hello. I’m doctor … Continued
https://www.certara.com/podcast/certara-talks-j-p-morgans-biotechshowcase-2024/How about a free demo of the Simcyp™ PBPK Simulator? Complete the form to book your no-obligation demo of the standard software for Population-based Physiologically Based Modeling and Simulation… and see how better off you could be with Simcyp!
https://www.certara.com/thank-you-attain-fda-label-claims-for-kinase-inhibitor-drugs-with-simcyp-brochure/The Simcyp™ Simulator has been used by large pharma and innovative biotech companies to inform, reduce and/or replace clinical studies for 40 Kinase Inhibitor (KI) drugs in the past decade. This 20+ year in silico technology has been accepted by global regulators, not just in oncology, but also inflammatory, rare, neurology and other diseases. While best known for … Continued
https://www.certara.com/attain-fda-label-claims-for-kinase-inhibitor-drugs-with-the-simcyp-simulator-without-the-need-to-run-clinical-studies/EBOOK PBPK Applications (MIFD) Using the Simcyp™ Simulator Welcome the Future of Biopharmaceutics Explore strategies, regulatory validation, and solutions through case studies in small-molecule human Physiologically Based Pharmacokinetic modeling (PBPK). Submit the form below to download your exclusive copy of the eBook and shape the future of pharmaceutical innovation! What you’ll learn How PBPK modeling … Continued
https://www.certara.com/pbpk-applications-mifd-using-the-simcyp-simulator/How about a free demo of the Simcyp™ PBPK Simulator? Complete the form to book your no-obligation demo of the standard software for Population-based Physiologically Based Modeling and Simulation… and see how better off you could be with Simcyp!
https://www.certara.com/thank-you-pbpk-applications-mifd-using-the-simcyp-simulator-ebook/